NCT06790147Not yet recruiting
Stenting for Ischemic Strokes Secondary to Medically Refractory Intracranial Atherosclerotic Disease
Stenting for Ischemic Strokes Secondary to Medically Refractory Intracranial Atherosclerotic Disease: STRICT-ICAS
Source: ClinicalTrials.gov · Last updated 16 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to establish a prospective multicenter registry of patients undergoing intracranial stenting for ischemic strokes caused by medically refractory ICAD. The study aims to evaluate current practice patterns, periprocedural outcomes, and delayed outcomes. Researchers will collect demographic and procedural data from patients who undergo intracranial stenting after having an ischemic stroke caused by medically refractory ICAD.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 17 Jan 2025
- Start date
- Aug 2025
- Primary completion date
- Aug 2027
- Lead sponsor
- Nitin Goyal
- Diseases
- Stroke
- NCT number
- NCT06790147
What you commit to
- Study type: Observational
- Planned participants: 150
- From Aug 2025 to the primary completion date, Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Performance of the endovascular procedure less than 3 days after the last stroke.
- Patients undergoing intracranial stenting for first stroke caused by ICAD
Other
- Large vessel occlusion strokes undergoing rescue intracranial stenting will not be included
- Baseline modified Rankin Scale (mRS) \>3
- Adult patients with ICAD resulting in \<70% vessel stenosis
Who the study is looking for
- Adult patients with ICAD resulting in 70-99% vessel stenosis who undergo PTAS with any device
- Patients will have to experience a stroke despite medical management involving risk factor modification and an antiplatelet agent
- Baseline modified Rankin Scale (mRS) ≤ 3
- Performance of the endovascular procedure at least 3 days after the last stroke
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Semmes Murphey Clinic Coordinator of this site? Confirm its status | Memphis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.